Back to today’s briefing

Story perspectives

Surge in GLP-1 Medications for Type 1 Diabetes Raises Concerns

4/9/2025

40 3

Summary

Story summary

A new study uncovers a surge in GLP-1 medications, such as Ozempic, among type 1 diabetes patients, largely due to escalating obesity rates. Yet, doctors warn of serious risks like hypoglycemia. While these drugs show promise for type 2 diabetes, their long-term impact on type 1 diabetes remains uncertain, highlighting the urgent need for more research.

1 of 1

Story summary

A new study uncovers a surge in GLP-1 medications, such as Ozempic, among type 1 diabetes patients, largely due to escalating obesity rates. Yet, doctors warn of serious risks like hypoglycemia. While these drugs show promise for type 2 diabetes, their long-term impact on type 1 diabetes remains uncertain, highlighting the urgent need for more research.